TRAIN2 PUBLICATIONS & ABSTRACTS
Clinical evidence from TRAIN2
![Neoadjuvant publications](https://agendia.com/wp-content/uploads/2024/03/neoadjuvant-publications.webp)
Evidence / Neoadjuvant / TRAIN2
TRAIN 2 Trial: BluePrint predicts response to neoadjuvant pertuzumab in HER2-positive
Breast Cancer Research 25, Article Number: 71 (2023) Authors: Liefaard et al.
Read More